China Universal Asset Management Co., Ltd. Altimmune, Inc. Transaction History

China Universal Asset Management Co., Ltd.

$893 Million
Q3 2024

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 May 21, 2024	BUY	$2.4 - $3.45 $1,699 - $2,442	708 Added 109.6%	1,354 $3,000
Q3 2023 Oct 30, 2023	BUY	$2.4 - $3.45 $1,699 - $2,442	708 Added 109.6%	1,354 $4,000
Q2 2023 May 21, 2024	SELL	$3.45 - $5.97 $75 - $131	-22 Reduced 3.29%	646 $2,000
Q2 2023 Jul 27, 2023	SELL	$3.45 - $5.97 $75 - $131	-22 Reduced 3.29%	646 $2,000
Q1 2023 May 21, 2024	BUY	$4.19 - $16.83 $708 - $2,844	169 Added 33.87%	668 $2,000
Q1 2023 Apr 27, 2023	BUY	$4.19 - $16.83 $708 - $2,844	169 Added 33.87%	668 $3,000
Q4 2022 May 21, 2024	BUY	$8.74 - $16.45 $4,361 - $8,208	499 New	499 $8,000
Q4 2022 Jan 31, 2023	BUY	$8.74 - $16.45 $349 - $658	40 Added 8.71%	499 $8,000
Q3 2022 Oct 21, 2022	BUY	$10.67 - $22.41 $4,897 - $10,286	459 New	459 $6,000

Others Institutions Holding ALT

# of Institutions

186

Shares Held

39.3M

Call Options Held

913K

Put Options Held

743K

Black Rock Inc. New York, NY

5.32M
Shares

$43.9 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

4.98M
Shares

$41.1 Million
0.0% of portfolio
Ameriprise Financial Inc Minneapolis, MN

3.88M
Shares

$32 Million
0.01% of portfolio
State Street Corp Boston, MA

3.41M
Shares

$28.2 Million
0.0% of portfolio
Tang Capital Management LLC San Diego, CA

2.75M
Shares

$22.7 Million
1.44% of portfolio

View Full List

About Altimmune, Inc.

Ticker ALT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,025,300
Market Cap $404M
Description
Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...

More about ALT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.

Account